Literature DB >> 20919420

Cefuroxime, an in vitro Comparison with Six Other Cephalosporins.

A L Barry, C Thornsberry, R N Jones, P C Fuchs, T L Gavan, E H Gerlach.   

Abstract

Entities:  

Year:  1977        PMID: 20919420      PMCID: PMC1543212     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN: 0035-9157


× No keyword cloud information.
  2 in total

1.  Susceptibility of Enterobacter to cefamandole: evidence for a high mutation rate to resistance.

Authors:  C M Findell; J C Sherris
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

2.  NEISSERIA GONORRHOEAE IDENTIFICATION IN DIRECT SMEARS BY A FLUORESCENT ANTIBODY-COUNTERSTAIN METHOD.

Authors:  L A WHITE; D S KELLOGG
Journal:  Appl Microbiol       Date:  1965-03
  2 in total
  17 in total

1.  Antimicrobial activity of Ro 15-8074, active metabolite of a new oral cephalosporin (Ro 15-8075), against 7,775 recent clinical isolates.

Authors:  R N Jones; P C Fuchs; A L Barry; L W Ayers; E H Gerlach; T L Gavan
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

2.  Antimicrobial activity, spectrum, and recommendations for disk diffusion susceptibility testing of ceftibuten (7432-S; SCH 39720), a new orally administered cephalosporin.

Authors:  R N Jones; A L Barry
Journal:  Antimicrob Agents Chemother       Date:  1988-10       Impact factor: 5.191

3.  Evaluation of cefamandole susceptibility testing of Enterobacteriacea by the autobac 1 system.

Authors:  P C de Girolami; L A Maher; M T Booth; D M St George
Journal:  J Clin Microbiol       Date:  1980-10       Impact factor: 5.948

4.  In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains.

Authors:  C N Baker; C Thornsberry; R N Jones
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

5.  Compound A49759, the 3-O-demethyl derivative of fortimicin A: in vitro comparison with six other aminoglycoside antibiotics.

Authors:  R N Jones; C Thornsberry; A L Barry; R R Packer; C N Baker; R E Badal
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

6.  Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin.

Authors:  C Thornsberry; A L Barry; R N Jones; C N Baker; R E Badal; R R Packer
Journal:  Antimicrob Agents Chemother       Date:  1980-08       Impact factor: 5.191

7.  Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testing.

Authors:  L W Ayers; R N Jones; A L Barry; C Thornsberry; P C Fuchs; T L Gavan; E H Gerlach; H M Sommers
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

Review 8.  Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-01       Impact factor: 9.546

9.  Evaluation of the cefonicid disk test criteria, including disk quality control guidelines.

Authors:  A L Barry; R N Jones; C Thornsberry
Journal:  J Clin Microbiol       Date:  1983-02       Impact factor: 5.948

10.  Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicin.

Authors:  R N Jones; P C Fuchs; A L Barry; T L Gavan; H M Sommers; E H Gerlach
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.